Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cyprus Healthcare Press.
Press releases published on August 28, 2025
SciSparc: AutoMax’s Shareholders Approve Merger with SciSparc
GlobeNewswire
·
August 28, 2025
TEL AVIV, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, …
The Science Behind Healthletic's First-Day Colostrum: Pioneering Whole-System Wellness Through Nature's Original Superfood
GlobeNewswire
·
August 28, 2025
Los Angeles, USA, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The Healthletic Mission: Redefining Wellness Through Transparency and Science Our Foundation Story Healthletic was founded on a simple yet revolutionary premise: wellness supplements should be transparent …
Clever Care Opens Flagship Community Center in Rowland Heights
GlobeNewswire
·
August 28, 2025
HUNTINGTON BEACH, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Clever Care, a culturally sensitive and competent Medicare Advantage plan, today announced the opening of its new flagship location. The community center will be located in Rowland Heights and is …
Berry Street Adds Veteran Commercial, Product, and Clinical Nutrition Experts to Leadership Team
GlobeNewswire
·
August 28, 2025
NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Berry Street, an AI-powered nutrition therapy platform, today announced three strategic appointments: Richard Fu has joined as the company’s first Chief Commercial Officer, Anita Khosla has joined as Chief …
Annual flu shots now available at Hannaford pharmacies
GlobeNewswire
·
August 28, 2025
SCARBOROUGH, Maine, Aug. 28, 2025 (GLOBE NEWSWIRE) -- To help prepare communities ahead of peak flu season, Hannaford is now offering flu shots at its in-store pharmacies in Maine, New Hampshire, New York, Massachusetts and Vermont. The Centers for Disease …
Codexis to Participate in Cantor Global Healthcare Conference
GlobeNewswire
·
August 28, 2025
REDWOOD CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced the Company will attend the Cantor Global …
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy
GlobeNewswire
·
August 28, 2025
SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, released new data¹ demonstrating that patients who used Omada’s virtual physical therapy (PT) program to address musculoskeletal ( …
Oncotelic Therapeutics Showcases Robust Pipeline and Founder’s Broad Intellectual Property Contributions to Biopharma Industry
GlobeNewswire
·
August 28, 2025
Highlighting multibillion-dollar drug discoveries and advancing novel oncology and immunotherapy assets AGOURA HILLS, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) (“OTLC” or the “Company”), a clinical stage …
Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition
GlobeNewswire
·
August 28, 2025
SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel affordable …
Tectonic Therapeutic to Participate in September Investor Conferences
GlobeNewswire
·
August 28, 2025
WATERTOWN, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of …
Can-Fite Reports H1 2025 Financial Results and Clinical Update
GlobeNewswire
·
August 28, 2025
Ramat Gan, Israel, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …
The International Myeloma Foundation Revives ‘Do You #kNOwMyeloma?’ for Blood Cancer Awareness Month 2025
GlobeNewswire
·
August 28, 2025
STUDIO CITY, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- With Blood Cancer Awareness Month coming up this September, the International Myeloma Foundation (IMF) is reviving and amplifying its highly successful #kNOwMyeloma campaign, centering on the question: …
PolarityBio to Share Regenerative Wound Healing Expertise at SAWC Fall 2025
GlobeNewswire
·
August 28, 2025
SALT LAKE CITY, Aug. 28, 2025 (GLOBE NEWSWIRE) -- PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative skin multicellular therapy, today announced its …
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss
GlobeNewswire
·
August 28, 2025
Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s continued commitment to its complex generic medicine portfolio …
Vericel to Present at the Wells Fargo Healthcare Conference on Thursday, September 4, 2025
GlobeNewswire
·
August 28, 2025
CAMBRIDGE, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will participate in a fireside chat at the Wells …
CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
August 28, 2025
VANCOUVER, Washington, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage biotechnology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with …
Aprea Therapeutics to Present at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
August 28, 2025
DOYLESTOWN, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments that exploit specific cancer cell vulnerabilities while …
CorMedix to Participate in Upcoming Investor Conferences
GlobeNewswire
·
August 28, 2025
BERKELEY HEIGHTS, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (“CorMedix”) (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced …
Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th
GlobeNewswire
·
August 28, 2025
LOS ANGELES, CA …
Moleculin Announces Exercise of Warrants for $6.0 Million Gross Proceeds
GlobeNewswire
·
August 28, 2025
HOUSTON, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced it …